BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35616161)

  • 1. REC8 inhibits proliferation, migration and invasion of breast cancer cells by targeting CDC20.
    He S; Liu D; Chen Z
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells.
    Shang G; Ma X; Lv G
    Cell Cycle; 2018; 17(1):43-52. PubMed ID: 28980876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-1321 and microRNA-7515 contribute to the progression of non-small cell lung cancer by targeting CDC20.
    Hu H; Tou FF; Mao WM; Xu YL; Jin H; Kuang YK; Han CB; Guo CY
    Kaohsiung J Med Sci; 2022 May; 38(5):425-436. PubMed ID: 35050556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of human breast cancer cells by tectorigenin through downregulation of matrix metalloproteinases and MAPK signaling in vitro.
    Zeng L; Yuan S; Shen J; Wu M; Pan L; Kong X
    Mol Med Rep; 2018 Mar; 17(3):3935-3943. PubMed ID: 29359782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma.
    Han J; Bai Y; Wang J; Xie XL; Li AD; Ding Q; Cui ZJ; Yin J; Jiang XY; Jiang HQ
    Clin Exp Med; 2021 Aug; 21(3):479-492. PubMed ID: 33677646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression.
    Yang C; Ge Y; Zang Y; Xu M; Jin L; Wang Y; Xu X; Xue B; Wang Z; Wang L
    Apoptosis; 2023 Dec; 28(11-12):1584-1595. PubMed ID: 37535214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC).
    Song C; Lowe VJ; Lee S
    Breast Cancer; 2021 Sep; 28(5):1073-1086. PubMed ID: 33813687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer‑associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‑493.
    Zhao Z; Xing Y; Liu Y; Jing S
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
    Wang X; Chen T
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REC8 regulates neuroblastoma cell proliferation, migration, invasion, and angiogenesis via STAT3/VEGF signaling.
    Wang Q; Fan W; Hao Z; Liang B; Fan M; Zhao Z; Li Z
    J Egypt Natl Canc Inst; 2023 Dec; 35(1):41. PubMed ID: 38105365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
    Deng Q; Wu L; Li Y; Zou L
    Adv Clin Exp Med; 2021 Sep; 30(9):957-966. PubMed ID: 34358419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
    Guo F; Zhu X; Zhao Q; Huang Q
    Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
    Yin Y; Cai J; Meng F; Sui C; Jiang Y
    Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
    Gu Y; Zhou Z
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
    Yang G; Wang G; Xiong Y; Sun J; Li W; Tang T; Li J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33907851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
    Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA‑222 promotes liver cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting BBC3.
    Liu Z; Sun J; Liu B; Zhao M; Xing E; Dang C
    Int J Mol Med; 2018 Jul; 42(1):141-148. PubMed ID: 29693134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladder cancer progression and potential underlying mechanisms.
    Liu Y; Zou SH; Gao X
    Genes Genomics; 2024 Apr; 46(4):437-449. PubMed ID: 38438666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.